← Back to Patent Explorer
US3872115A Expired / Lapsed US ⏱️ 0.0 years remaining

Cephalosporins

Assignee: Takeda Pharmaceutical Co Ltd
•
Filing: 1972-05-31
•
Granted: 1975-03-18
•
Expires: 1992-05-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract WHEREIN R1 is an acyl group, R2 and R3 represent hydrogen, a lower alkyl group, carboxylic group, amino group, dimethylamino group or hydroxymethyl group, respectively, or R2 and R3 may be bonded to form -NH-CH N- group. These cephalosporins have a broad antimicrobial spectrum. They are, in particular, effective against colitis germs (Escherichia coli) at a lower concentration. Example thereof include 7-(2-thienylacetamido)-3(2-oxopyrimidin-4-ylthio)-methylceph-3-em-4 -carboxylic acid, 7(phenyl-acetamido)- 3-(2-oxopyrimidin-4-ylthio)-methylceph-3-em4-carboxylic acid, 7-(phenoxyacetamido)3-(2-oxopyrimidin-4ylthio)-methylceph-3-em-4-carboxylic acid and 7-(2-thienylacetamido)-3-(2-oxo-6-methylpyrimidin-4-ylthio)-methylceph-3-em4-carboxylic acid. Novel cephalosporin compounds of the formula,

Inventors

  • 👤 Keiichi Sugimoto
  • 👤 Kunio Kobayashi
  • 👤 Kouji Nishijima
  • 👤 Shiro Morimoto

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 03:16
CPC Classifications
C; C07; C07D; C07D501/00; C07D501/14; C07D501/16; C07D501/20; C07D501/24; C07D501/36; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/06; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 31
Claim 1
Independent Claim 5 words
A COMPOUND OF THE FORMULA
Claim 2
Dependent Claim 5 words
A COMPOUND OF THE FORMULA
Claim 3
Dependent Claim 11 words
A compound according to claim 1, wherein R1 is 2-thienylacetyl group.
Claim 4
Dependent Claim 11 words
A compound according to claim 1, wherein R1 is phenylacetyl group.
Claim 5
Dependent Claim 11 words
A compound according to claim 1, wherein R1 is phenylthioacetyl group.
Claim 6
Dependent Claim 14 words
A compound according to claim 1, wherein both R2 and R3 are hydrogen atoms.
Claim 7
Dependent Claim 21 words
A compound according to claim 1, wherein one of R2 and R3 is methyl group and the other is hydrogen atom.
Claim 8
Dependent Claim 10 words
A compound claimed in claim 1, namely 7-(2-thienylacetamido)-3-(2-oxopyrimidin-4-ylthio)-methylceph-3-em-4 -carboxylic acid.
Claim 9
Dependent Claim 9 words
A compound claimed in claim 1, namely 7-(phenylacetamido)-3-(2-oxopyrimidin-4-ylthio)-methylceph-3-em-4-carboxylic acid.
Claim 10
Dependent Claim 10 words
A compound claimed in claim 1, namely 7-(phenoxyacetamido)-3-(2-oxopyrimidin-4-ylthio)-methylceph-3-em-4 -carboxylic acid.
Claim 11
Dependent Claim 10 words
A cOmpound claimed in claim 1, namely 7-(2-thienylacetamido)-3-(2-oxo-6-methylpyrimidin-4-ylthio)-methylceph-3-em -4-carboxylic acid.
Claim 12
Dependent Claim 11 words
A compound according to claim 1, namely 7-( Alpha -carboxyphenylacetamido)-3-(2-oxo-5-methylpyrimidin-4-ylthio-methylceph-3-em-4-carboxylic acid.
Claim 13
Dependent Claim 12 words
A compound according to claim 1, wherein R4 is phenyl or thienyl.
Claim 14
Dependent Claim 10 words
A compound according to claim 12, wherein R4 is phenyl.
Claim 15
Dependent Claim 13 words
A compound according to claim 1, wherein R5 is amino, carboxyl or sulfo.
Claim 16
Dependent Claim 10 words
A compound according to claim 14, wherein R5 is carboxyl.
Claim 17
Dependent Claim 10 words
A compound according to claim 1, wherein R2 is methyl.
Claim 18
Dependent Claim 10 words
A compound according to claim 1, wherein R3 is hydrogen.
Claim 19
Dependent Claim 23 words
A compound according to claim 1, wherein said compound is an acid or a salt of sodium, potassium, magnesium, calcium, aluminum or triethylamine.
Claim 20
Dependent Claim 26 words
A compound according to claim 1, wherein R4 is selected from the group consisting of phenyl, phenoxy, thienyl and phenylthio and further wherein R5 is hydrogen.
Claim 21
Dependent Claim 10 words
A compound according to claim 19, wherein R4 is phenyl.
Claim 22
Dependent Claim 10 words
A compound according to claim 19, wherein R4 is phenoxy.
Claim 23
Dependent Claim 10 words
A compound according to claim 19, wherein R4 is thienyl.
Claim 24
Dependent Claim 10 words
A compound according to claim 19, wherein R4 is phenylthio.
Claim 25
Dependent Claim 14 words
A compound according to claim 19, wherein both R2 and R3 are hydrogen atoms.
Claim 26
Dependent Claim 23 words
A compound according to claim 19, wherein one of R2 and R3 is a methyl group and the other is a hydrogen atom.
Claim 27
Dependent Claim 10 words
A compound according to claim 19, wherein R2 is methyl.
Claim 28
Dependent Claim 10 words
A compound according to claim 19, wherein R3 is hydrogen.
Claim 29
Dependent Claim 24 words
A compound according to claim 19, wherein said compound is an acid or a salt of sodium, potassium, magnesium, calcium, aluminum or triethyl amine.
Claim 30
Dependent Claim 12 words
A compound according to claim 19, namely disodium 7-( Alpha -carboxyphenylacetamido)-3-(2-oxo-5-methylpyrimidin-4-ylthio)-methylceph-3 -em-4-carboxylate.
Claim 31
Dependent Claim 9 words
A compound according to claim 19, namely 7-(2-thienylacetamido)-3-(2-oxo-5-methyl-pyrimidin-4-ylthio)-methylceph-3-em-4-carboxylic acid.

References Cited (Backward Citations)

US3673183A Cited
US3663540A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-03-17 1978-09-16 1979-03-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-03-17 1982-09-16 1983-03-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-03-17 1986-09-16 1987-03-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag